B of A Securities Downgrades Outset Medical to Underperform, Lowers Price Target to $3
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Travis Steed has downgraded Outset Medical (NASDAQ:OM) from Buy to Underperform and lowered the price target from $32 to $3.
October 13, 2023 | 12:19 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Outset Medical's stock has been downgraded to Underperform by B of A Securities, with a significantly reduced price target of $3, down from $32.
The downgrade from Buy to Underperform and the significant reduction in price target by a major analyst like B of A Securities is likely to negatively impact investor sentiment and could lead to a decrease in the stock price of Outset Medical in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100